Ausgabe 1/2002
Inhalt (16 Artikel)
Elucidation of the potential roles of matrix metalloproteinases in skeletal biology
Stephen M Krane
Collagen-induced arthritis is exacerbated in IL-10-deficient mice
Alison Finnegan, Charles D Kaplan, Yanxia Cao, Hermann Eibel, Tibor T Glant, Jian Zhang
Investigation of infectious agents associated with arthritis by reverse transcription PCR of bacterial rRNA
Charles J Cox, Karen E Kempsell, J S Hill Gaston
Drugs in development: bisphosphonates and metalloproteinase inhibitors
Jon B Catterall, Tim E Cawston
The relationship between predicted peptide–MHC class II affinity and T-cell activation in a HLA-DRβ1*0401 transgenic mouse model
Jonathan A Hill, Dequn Wang, Anthony M Jevnikar, Ewa Cairns, David A Bell
Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis
Tao Jin, Andrej Tarkowski, Peter Carmeliet, Maria Bokarewa
Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
Thomas A Einhorn
The angiogenesis inhibitor protease-activated kringles 1–5 reduces the severity of murine collagen-induced arthritis
Percy F Sumariwalla, Yihai Cao, Hua-Lin Wu, Marc Feldmann, Ewa M Paleolog Dr
Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
Debabrata Mukherjee, Eric J Topol
Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegener's granulomatosis
Peter Lamprecht, Anika Erdmann, Antje Mueller, Elena Csernok, Eva Reinhold-Keller, Konstanze Holl-Ulrich, Alfred C Feller, Hilke Bruehl, Wolfgang L Gross
Exposure to receptor-activator of NFκB ligand renders pre-osteoclasts resistant to IFN-γ by inducing terminal differentiation
Willis Huang, Regis J O'Keefe, Edward M Schwarz
Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology
Sally Roberts, Iain W McCall, Alan J Darby, Janis Menage, Helena Evans, Paul E Harrison, James B Richardson
Adult mesenchymal stem cells and cell-based tissue engineering
Rocky S Tuan, Genevieve Boland, Richard Tuli
COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease
Leslie J Crofford